156 related articles for article (PubMed ID: 3928727)
1. Amiodarone: risk factors for recurrence of symptomatic ventricular tachycardia identified at electrophysiologic study.
Naccarelli GV; Fineberg NS; Zipes DP; Heger JJ; Duncan G; Prystowsky EN
J Am Coll Cardiol; 1985 Oct; 6(4):814-21. PubMed ID: 3928727
[TBL] [Abstract][Full Text] [Related]
2. Chronic effects of amiodarone in patients with refractory ventricular tachycardia.
Saksena S; Rothbart ST; Cappello G
Int J Cardiol; 1983 Jun; 3(3):339-52. PubMed ID: 6347914
[TBL] [Abstract][Full Text] [Related]
3. Prospective evaluation of a discriminant function for prediction of recurrent symptomatic ventricular tachycardia or ventricular fibrillation in coronary artery disease patients receiving amiodarone and having inducible ventricular tachycardia at electrophysiologic study.
Klein LS; Fineberg N; Heger JJ; Miles WM; Kammerling JM; Chang MS; Zipes DP; Prystowsky EN
Am J Cardiol; 1988 May; 61(13):1024-30. PubMed ID: 3364357
[TBL] [Abstract][Full Text] [Related]
4. Results of late programmed electrical stimulation and long-term electrophysiologic effects of amiodarone therapy in patients with refractory ventricular tachycardia.
Veltri EP; Reid PR; Platia EV; Griffith LS
Am J Cardiol; 1985 Feb; 55(4):375-9. PubMed ID: 3969872
[TBL] [Abstract][Full Text] [Related]
5. Amiodarone therapy: role of early and late electrophysiologic studies.
Greenspon AJ; Volosin KJ; Greenberg RM; Jefferies L; Rotmensch HH
J Am Coll Cardiol; 1988 Jan; 11(1):117-23. PubMed ID: 3335688
[TBL] [Abstract][Full Text] [Related]
6. Long-term clinical outcome of ventricular tachycardia or fibrillation treated with amiodarone.
McGovern B; Garan H; Malacoff RF; DiMarco JP; Grant G; Sellers TD; Ruskin JN
Am J Cardiol; 1984 Jun; 53(11):1558-63. PubMed ID: 6731300
[TBL] [Abstract][Full Text] [Related]
7. QT prolongation and the antiarrhythmic efficacy of amiodarone.
Torres V; Tepper D; Flowers D; Wynn J; Lam S; Keefe D; Miura DS; Somberg JC
J Am Coll Cardiol; 1986 Jan; 7(1):142-7. PubMed ID: 3941202
[TBL] [Abstract][Full Text] [Related]
8. Amiodarone in patients with recurrent sustained ventricular tachyarrhythmias: results of programmed electrical stimulation and long-term clinical outcome in chronic treatment.
Schmitt C; Brachmann J; Waldecker B; Rizos I; Senges J; Kübler W
Am Heart J; 1987 Aug; 114(2):279-83. PubMed ID: 3604883
[TBL] [Abstract][Full Text] [Related]
9. Clinical efficacy and electrophysiology during long-term therapy for recurrent ventricular tachycardia or ventricular fibrillation.
Heger JJ; Prystowsky EN; Jackman WM; Naccarelli GV; Warfel KA; Rinkenberger RL; Zipes DP
N Engl J Med; 1981 Sep; 305(10):539-45. PubMed ID: 6789201
[TBL] [Abstract][Full Text] [Related]
10. Amiodarone in the management of patients with ventricular tachycardia and ventricular fibrillation.
Morady F; Scheinman MM; Hess DS
Pacing Clin Electrophysiol; 1983 May; 6(3 Pt 1):609-15. PubMed ID: 6191299
[TBL] [Abstract][Full Text] [Related]
11. Utility of ambulatory electrocardiographic monitoring for predicting recurrence of sustained ventricular tachyarrhythmias in patients receiving amiodarone.
Sokoloff NM; Spielman SR; Greenspan AM; Rae AP; Brady PM; Kay HR; Horowitz LN
J Am Coll Cardiol; 1986 Apr; 7(4):938-41. PubMed ID: 3958353
[TBL] [Abstract][Full Text] [Related]
12. Disparity between the clinical and electrophysiologic effects of amiodarone in the treatment of recurrent ventricular tachyarrhythmias.
Hamer AW; Finerman WB; Peter T; Mandel WJ
Am Heart J; 1981 Dec; 102(6 Pt 1):992-1000. PubMed ID: 7315716
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of electrophysiologic testing in evaluation of amiodarone therapy for sustained ventricular tachyarrhythmias associated with coronary heart disease.
Horowitz LN; Greenspan AM; Spielman SR; Webb CR; Morganroth J; Rotmensch H; Sokoloff NM; Rae AP; Segal BL; Kay HR
Am J Cardiol; 1985 Feb; 55(4):367-71. PubMed ID: 3969870
[TBL] [Abstract][Full Text] [Related]
14. Effects of amiodarone on supraventricular tachycardia involving bypass tracts.
Alboni P; Shantha N; Pirani R; Baggioni F; Scarfo S; Tomasi AM; Masoni A
Am J Cardiol; 1984 Jan; 53(1):93-8. PubMed ID: 6691283
[TBL] [Abstract][Full Text] [Related]
15. Effects of intravenous amiodarone in patients with inducible repetitive ventricular responses and ventricular tachycardia.
Hariman RJ; Gomes JA; Kang PS; El-Sherif N
Am Heart J; 1984 Jun; 107(6):1109-17. PubMed ID: 6720537
[TBL] [Abstract][Full Text] [Related]
16. Antiarrhythmic efficacy of amiodarone in recurrent ventricular tachycardia evaluated by multiple electrophysiological and ambulatory ECG recordings.
Rasmussen K; Winkle R; Ross D; Griffin J; Peters F; Mason J
Acta Med Scand; 1982; 212(6):367-74. PubMed ID: 6760675
[TBL] [Abstract][Full Text] [Related]
17. Cardiac arrest and sudden death in patients treated with amiodarone for sustained ventricular tachycardia or ventricular fibrillation: risk stratification based on clinical variables.
DiCarlo LA; Morady F; Sauve MJ; Malone P; Davis JC; Evans-Bell T; Winston SA; Scheinman MM
Am J Cardiol; 1985 Feb; 55(4):372-4. PubMed ID: 3969871
[TBL] [Abstract][Full Text] [Related]
18. Effect of amiodarone on electric induction, morphology, and rate of ventricular tachycardia and its relation to clinical efficacy.
Reddy CP; Kuo CS; Jivrajka V
Pacing Clin Electrophysiol; 1984 Nov; 7(6 Pt 1):1055-62. PubMed ID: 6209624
[TBL] [Abstract][Full Text] [Related]
19. Amiodarone therapy in symptomatic, sustained refractory atrial and ventricular tachyarrhythmias.
Podrid PJ; Lown B
Am Heart J; 1981 Apr; 101(4):374-9. PubMed ID: 7211665
[TBL] [Abstract][Full Text] [Related]
20. Combined mexiletine and amiodarone treatment of refractory recurrent ventricular tachycardia.
Waleffe A; Mary-Rabine L; Legrand V; Demoulin JC; Kulbertus HE
Am Heart J; 1980 Dec; 100(6 Pt 1):788-93. PubMed ID: 7446381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
